Insider filing · ALKS
nancy lynn MD snyderman
Director
profile →
Alkermes plc
ALKS · Healthcare · 32 filings in 24 months
ticker →
nancy lynn MD snyderman sold $2.2M of Alkermes (ALKS)
Executed Aug 3, disclosed Aug 3, the same day.
Value, as filed
$2.2M
44,472 sh × $50.35
Executed
Aug 3
the trade date, as filed
Disclosed
Aug 3
0 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
NSnancy lynn MD snyderman (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Alkermes plc (ALKS). The largest single filing was $2.2M of ALKS (44,472 sh × $50.35, as filed), executed Aug 3.
The name
ALKSHealthcare · Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to addres…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→